Bilateral Native Renal Vein Thrombosis in a Liver and Kidney Transplant Recipient

Introduction: Renal vein thrombosis (RVT) is a rare condition predominantly linked to nephrotic syndrome, hereditary hypercoagulable disorders, malignancies, and sepsis in adults. The incidence of native RVT after simultaneous liver and kidney transplantation (SLKT) is unknown. In this case, we present an incidental finding of bilateral native kidney vein thrombosis in a liver and kidney transplant recipient. Case Description: A 44-year-old male received SLKT. Thirteen months post-transplant, bilateral native renal vein thrombosis extending into the inferior vena cava (IVC) below the diaphragm appeared on a CT scan during a preop workup for incisional hernia repair. The renal allograft was free of venous thrombosis based on the CT scan and a Doppler study. A focused investigation for the underlying cause of thrombosis ensued. The family history of thromboembolism was negative. Tests including Lupus anti-coagulant; anti-cardiolipin IgG and IgM; anti-beta-2 Glycoprotein IgG and IgM; factor V Leiden and prothrombin (20210G>A) mutations yielded negative results. Genetic mutations implicated in myeloproliferative neoplasm including JAK2 (V617F), Calreticulin (CALR Exon 9), and MPL mutations were not detected. Similarly, paroxysmal nocturnal hemoglobinuria was ruled out by flow cytometry. The function of the renal and liver allografts remained stable, and proteinuria was not detected. With apixaban treatment, a CT scan showed complete resolution of the bilateral native renal vein thrombosis after 3 months. Discussion: This case highlights the incidental finding of native RVT after SLKT, a pathology with an unknown clinical incidence. When found, it warrants a complete comprehensive workup for an underlying etiology. The most efficacious type and duration of anticoagualation is unknown, and this decision should be multi-disciplinary and collaborative with the patient.Bilateral RVT extending into the IVC with renal vein dilation (yellow arrows).

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024kfywz4kn
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bilateral Native Renal Vein Thrombosis in a Liver and Kidney Transplant Recipient

Kawther F. Alquadan, Amer Ashaab Belal, Andrew Slater, Alfonso Santos et al.
Journal of the American Society of Nephrology
Renal Transplantation Outcomes and Treatments
article

Bilateral Native Renal Vein Thrombosis in a Liver and Kidney Transplant Recipient

Kawther F. Alquadan, Amer Ashaab Belal, Andrew Slater, Alfonso Santos, Rohan V. Mehta
article en

Abstract

Introduction: Renal vein thrombosis (RVT) is a rare condition predominantly linked to nephrotic syndrome, hereditary hypercoagulable disorders, malignancies, and sepsis in adults. The incidence of native RVT after simultaneous liver and kidney transplantation (SLKT) is unknown. In this case, we present an incidental finding of bilateral native kidney vein thrombosis in a liver and kidney transplant recipient. Case Description: A 44-year-old male received SLKT. Thirteen months post-transplant, bilateral native renal vein thrombosis extending into the inferior vena cava (IVC) below the diaphragm appeared on a CT scan during a preop workup for incisional hernia repair. The renal allograft was free of venous thrombosis based on the CT scan and a Doppler study. A focused investigation for the underlying cause of thrombosis ensued. The family history of thromboembolism was negative. Tests including Lupus anti-coagulant; anti-cardiolipin IgG and IgM; anti-beta-2 Glycoprotein IgG and IgM; factor V Leiden and prothrombin (20210G>A) mutations yielded negative results. Genetic mutations implicated in myeloproliferative neoplasm including JAK2 (V617F), Calreticulin (CALR Exon 9), and MPL mutations were not detected. Similarly, paroxysmal nocturnal hemoglobinuria was ruled out by flow cytometry. The function of the renal and liver allografts remained stable, and proteinuria was not detected. With apixaban treatment, a CT scan showed complete resolution of the bilateral native renal vein thrombosis after 3 months. Discussion: This case highlights the incidental finding of native RVT after SLKT, a pathology with an unknown clinical incidence. When found, it warrants a complete comprehensive workup for an underlying etiology. The most efficacious type and duration of anticoagualation is unknown, and this decision should be multi-disciplinary and collaborative with the patient.Bilateral RVT extending into the IVC with renal vein dilation (yellow arrows).

Journal of the American Society of NephrologyVol. 35(10S)
University of Florida (US)
Zero hunger
Openalex Percentile: Top 62%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.